Jeffrey H. Cooper is CFO & SVP at BIOMARIN PHARMACEUTICAL INC (BMRN). They have made 7 open-market trades across 1 company since 2006, most recently 2012-05-14.
CIK 0001301173
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $15K since 2008, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BMRN | 41,089 | $2.3M |
Shares reported on the most recent Form 4, priced at the 2012-05-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BMRN | SELL · 10b5-1 | 2012-05-14 | 2012-05-16 | $38.09 | $962K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2012-02-24 | 2012-02-28 | $35.07 | $2.9M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-01-03 | 2012-01-05 | $34.75 | $87K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2011-11-01 | 2011-11-03 | $33.26 | $83K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2011-10-10 | 2011-10-11 | $34.00 | $625K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2011-09-28 | 2011-09-29 | $32.00 | $588K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2011-09-01 | 2011-09-06 | $29.41 | $74K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2011-08-02 | 2011-08-04 | $30.47 | $550K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2011-07-14 | 2011-07-18 | $30.00 | $551K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2011-07-01 | 2011-07-06 | $27.50 | $69K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2011-05-26 | 2011-05-31 | $27.50 | $481K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2010-11-24 | 2010-11-24 | $27.50 | $309K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2010-10-29 | 2010-11-01 | $25.32 | $728K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2010-10-25 | 2010-10-27 | $24.00 | $365K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2010-09-13 | 2010-09-15 | $22.85 | $137K | -18.2% | +2.1% | +2.1% |
| BMRN | BUY | 2008-04-30 | 2008-07-08 | $13.95 | $15K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2008-02-29 | 2008-03-04 | $37.62 | $1.9M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2008-02-29 | 2008-03-04 | $37.94 | $224K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2007-10-08 | 2007-10-12 | $26.00 | $322K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2007-09-26 | 2007-09-27 | $24.50 | $306K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2007-09-06 | 2007-09-07 | $22.50 | $305K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2007-08-17 | 2007-08-20 | $20.29 | $406K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2007-08-08 | 2007-08-09 | $21.00 | $263K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2006-12-06 | 2006-12-08 | $18.00 | $261K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2006-08-29 | 2006-08-31 | $16.00 | $416K | -18.2% | +2.1% | +2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.